Tissue decellularization

Inactive Publication Date: 2001-05-03
CRYOLIFE
View PDF0 Cites 61 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

9. FIGS. 1A and B show the effect of decellularization on the extensibility of and elastic modulus of aortic and pulmonary leaflets.
10. FIGS. 2A and B show the effect of decellularization on rates of stress-relaxation of aortic and pulmonary leaflets.
11. FIGS. 3A, B

Problems solved by technology

2. Cardiac valve disorders can be serious and in fact are often fatal.
3. While bioprosthetic valves have a number of advantages over mechanical valves, including a lower risk of comp

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tissue decellularization
  • Tissue decellularization
  • Tissue decellularization

Examples

Experimental program
Comparison scheme
Effect test

example ii

Experimental details

39. Porcine heart valves. Porcine hearts were obtained from market weight pigs (>120 kg). After rinsing in sterile phosphate buffered saline, the hearts were field dissected (apex removed) and shipped at 4.degree.C. in sterile PBS. All hearts arrived within 24 hr of animal slaughter. Aortic and pulmonary valves were dissected as roots. These tissues were subjected to a bioburden reduction step of incubation in a mixture of antibiotics and antimycotics for 48 hr at 48.degree.C. The disinfected tissues were either cryopreserved (10% (v / v) DMSO and 10% (v / v) fetal bovine serum, -1.degree. C. / min) or were decellularized by a procedure involving treatment with hypotonic medium followed by digestion with a mixture of deoxyribonuclease I and ribonuclease A. After 12 days, the decellularized valves were either cryopreserved as above or chemically fixed in 0.35% (w / v) glutaraldehyde at 2 mmHg in phosphate buffered saline (pH 7.4) for a total of 7 days; the low pressure fi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates, in general, to tissue decellularization and, in particular to a method of treating tissues, for example, heart valves, tendons and ligaments, so as to render them acellular and thereby limit mineralization and/or immunoreactivity upon implementation in vivo.

Description

1. The present invention relates, in general, to tissue decellularization and, in particular to a method of treating tissues, for example, heart valves, ligaments and tendons, so as to render them acellular and thereby limit mineralization and / or immunoreactivity upon implantation in vivo.2. Cardiac valve disorders can be serious and in fact are often fatal. Treatment may require replacement of the valve with a prosthetic valve--mechanical or bioprosthetic. Bioprosthetic valves typically include a leaflet portion and a vascular conduit portion, both generally of a biological material, and possibly a stent.3. While bioprosthetic valves have a number of advantages over mechanical valves, including a lower risk of complications resulting from thrombus formation, they are associated with a higher risk of mineralization. This increased risk significantly limits the durability of the replacement valve. The present invention provides a method of rendering tissues, including heart valves, r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61F2/24A61L17/00A61L27/00A61F2/02A61L27/36C12N5/06
CPCA61F2/2415A61L27/3604A61L27/3683A61L27/3687A61L27/3695A61L2430/40Y10S623/915Y10S623/916Y10S623/918A61L2400/02
Inventor GOLDSTEIN, STEVENBLACK, KIRBY S.
Owner CRYOLIFE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products